Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily L Heil

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
The Journal of Infectious Diseases|July 22, 2020
Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A ReviewKady Phe, Emily L Heil, Vincent H Tam
The Journal of Infectious Diseases|July 22, 2020
Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial ResistanceJeffrey R Strich, Emily L Heil, Henry Masur
Antimicrobial Agents and Chemotherapy|March 19, 2021
Erratum for Kalaria et al., "A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients"Shamir N Kalaria, Mathangi Gopalakrishnan, Emily L Heil
Emergency Medicine Clinics of North America|December 3, 2016
Appropriate Antibiotic TherapyMichael G Allison, Emily L Heil, Bryan D Hayes
Expert Opinion on Pharmacotherapy|October 23, 2018
The antibiotic arms race: current and emerging therapy for <i>Klebsiella pneumoniae</i> carbapenemase (KPC) - producing bacteriaMichael E Plazak, Pranita D Tamma, Emily L Heil
BMJ (Clinical Research Ed.)|November 25, 2020
Remdesivir: a pendulum in a pandemicIlan S Schwartz, Emily L Heil, Erin K McCreary
Expert Opinion on Pharmacotherapy|October 22, 2020
An evaluation of meropenem/vaborbactam for the treatment of nosocomial pneumoniaLauren M Groft, Kimberly C Claeys, Emily L Heil
AIDS (London, England)|October 4, 2021
Probable hepatotoxicity from two second-generation integrase strand transfer inhibitorsEmily L Heil, Neha Sheth Pandit, Gregory H Taylor
Antimicrobial Agents and Chemotherapy|May 25, 2021
New Perspectives on Antimicrobial Agents: CefiderocolErin K McCreary, Emily L Heil, Pranita D Tamma
Antimicrobial Agents and Chemotherapy|April 11, 2022
In a Pinch: Cefiderocol for CRAB InfectionsSara M Karaba, Elizabeth B Hirsch, Emily L Heil
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
The Journal of Infectious Diseases|July 22, 2020
Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A ReviewKady Phe, Emily L Heil, Vincent H Tam
The Journal of Infectious Diseases|July 22, 2020
Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial ResistanceJeffrey R Strich, Emily L Heil, Henry Masur
Antimicrobial Agents and Chemotherapy|March 19, 2021
Erratum for Kalaria et al., "A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients"Shamir N Kalaria, Mathangi Gopalakrishnan, Emily L Heil
Emergency Medicine Clinics of North America|December 3, 2016
Appropriate Antibiotic TherapyMichael G Allison, Emily L Heil, Bryan D Hayes
Expert Opinion on Pharmacotherapy|October 23, 2018
The antibiotic arms race: current and emerging therapy for <i>Klebsiella pneumoniae</i> carbapenemase (KPC) - producing bacteriaMichael E Plazak, Pranita D Tamma, Emily L Heil
BMJ (Clinical Research Ed.)|November 25, 2020
Remdesivir: a pendulum in a pandemicIlan S Schwartz, Emily L Heil, Erin K McCreary
Expert Opinion on Pharmacotherapy|October 22, 2020
An evaluation of meropenem/vaborbactam for the treatment of nosocomial pneumoniaLauren M Groft, Kimberly C Claeys, Emily L Heil
AIDS (London, England)|October 4, 2021
Probable hepatotoxicity from two second-generation integrase strand transfer inhibitorsEmily L Heil, Neha Sheth Pandit, Gregory H Taylor
Antimicrobial Agents and Chemotherapy|May 25, 2021
New Perspectives on Antimicrobial Agents: CefiderocolErin K McCreary, Emily L Heil, Pranita D Tamma
Antimicrobial Agents and Chemotherapy|April 11, 2022
In a Pinch: Cefiderocol for CRAB InfectionsSara M Karaba, Elizabeth B Hirsch, Emily L Heil
Pageof 12